FDA allows marketing of clot retrieval devices to reduce disability in stroke patients - FDA Press Releases

The U.S. Food and Drug Administration today allowed marketing of two Trevo clot retrieval devices as an initial therapy for strokes due to blood clots (ischemic) to reduce paralysis, speech difficulties and other stroke disabilities. These devices should be used within six hours of symptom onset and only following treatment with a clot-dissolving drug (tissue plasminogen activator or t-PA), which needs to be given within three hours of symptom onset.

from Food and Drug Administration--Press Releases http://ift.tt/2caKJsy
via IFTTT